Rheumatoid Arthritis Clinical Trials

Rheumatoid Arthritis Clinical Trial

Compensation

Up to $1,900

For Completed Study

Rheumatoid Arthritis Clinical research study

Diagnosed With Rheumatoid Arthritis?

Do you have Rheumatoid Arthritis (RA) and want to support advancements in medical research? Consider joining our clinical trial to explore potential new treatment options while being compensated for your time and participation.

Check your eligibility, learn more about the trial process, and discover how you can help shape the future of RA treatments. Sign up below to get started!

are you interested in our clinical trial?

Rheumatoid Arthritis (RA) Study Eligibility

You could be eligible to participate in one of these research studies if you meet the following criteria:

Rheumatoid Arthritis Trial Eligibility Criteria

  • Age 18+

  • Have been diagnosed with Rheumatoid Arthritis, Active Rheumatoid Arthritis Disease Activity, currently taking medications for Rheumatoid Arthritis

two Convenient pinellas county locations

Study Locations

clearwater clinical research facility

Clearwater Facility

Enroll Now

2147 NE Coachman Road
Clearwater, FL 33765
727-466-0078

Tampa clinical research facility

Tampa Facility

Enroll Now

605 N. Howard Ave.
Tampa, FL 33606
813-870-1292

Protocol: DRI17821 & IA-14069_1b | Indication: Rheumatoid Arthritis

What To Know About Volunteering For One Of Our Rheumatoid Arthritis Clinical Trials

Participating in a clinical trial is entirely your choice, and you are free to withdraw at any time. The process is designed to be straightforward and supportive, beginning with finding a trial that suits you, consulting with the study team to assess eligibility, reviewing and signing an informed consent form, completing necessary screening tests, and enrolling if you qualify.

RA Clinical Trial

Step 1:

Determine Eligibility

Fill out our online form below to see if you’re eligible for one of our RA Clinical Trials.

RA paid trial

Step 2:

Participate In The Study

Our clinical studies include up to eight office visits over a span of approximately 20 weeks, with one visit potentially involving a compensated two-night stay.

Clinical Trial Rheumatoid Arthritis

Step 3:

Compensation For Time/Travel

If you qualify, all study-related care is provided at no cost. Compensation may be provided for time and travel.

Why Participate in a Clinical Trial?

For individuals diagnosed with Rheumatoid Arthritis, participating in a clinical trial offers a chance to explore new treatment options designed to manage and relieve symptoms.

  • Study-related exams at no cost

  • The opportunity to try new treatments that could be more effective than conventional options

  • No insurance required for treatment

  • Contribute to future medical advances for Rheumatoid Arthritis

RA Clinical Study

want to learn more?

What is Rheumatoid Arthritis (RA)?

Rheumatoid Arthritis (RA) is a chronic autoimmune disorder where the immune system mistakenly attacks the body’s joints, leading to inflammation, pain, and potential joint damage. Unlike osteoarthritis, which results from wear and tear, RA is an inflammatory condition that can affect multiple joints simultaneously, commonly starting in the hands, wrists, and knees.

The symptoms of RA can vary, but typical signs include:

  • Joint pain, stiffness, and swelling, particularly in the morning or after periods of rest
  • Fatigue and a general feeling of illness
  • Redness and warmth around affected joints
  • Loss of joint function and flexibility
  • In some cases, RA can affect other organs, such as the lungs or eyes

While there is no cure for RA, there are many treatments available to help manage symptoms, slow disease progression, and improve quality of life. Medications, physical therapy, and lifestyle changes are commonly used to reduce inflammation and preserve joint function.

More Detailed Information

Frequently Asked Questions

Rheumatoid arthritis clinical trials at CRWF are research studies that investigate new treatments and therapies aimed at improving the management of RA. These trials are crucial for advancing our understanding of the disease and developing better treatment options. Participants in RA clinical trials may receive either the investigational medication or a placebo, in a randomized, double-blind study format. In this setup, neither the participant nor the research team knows which treatment is being given, ensuring the study’s results are unbiased.

Participants in RA clinical trials can expect detailed monitoring and regular check-ins with medical professionals. During the trial, participants will undergo comprehensive evaluations to assess joint function, pain levels, and overall health. They will also be provided with education on RA management and receive personalized care from specialists in the field. This support ensures that participants are well cared for while contributing to important research.

Clinical trials for RA are exploring a wide variety of treatment options, including biologic therapies, small molecules, and targeted therapies aimed at controlling the immune response that causes inflammation. These treatments work to reduce disease activity, improve joint function, and ultimately provide relief from the debilitating symptoms of RA. By participating in these trials, individuals have access to the most innovative treatments available.

Understanding Placebo-Controlled Studies in Rheumatoid Arthritis Research

Placebo-controlled studies are a cornerstone of RA clinical trials. In these studies, one group of participants receives the experimental treatment, while the other group receives a placebo, an inactive substance. This allows researchers to assess the true effectiveness of the study medication. Understanding the role of the placebo is vital for participants, as it helps ensure the integrity and reliability of the results.

Evaluating the Efficacy of These New Medications and Therapies

The goal of RA clinical trials is to determine whether new treatments effectively reduce disease activity, improve symptoms, and prevent further joint damage. Researchers monitor participants closely to track the impact of the therapy on inflammation and overall joint function. This evaluation process is essential for understanding whether the new treatment could eventually become a standard of care for RA patients.

Access to Cutting-Edge Treatments for Rheumatoid Arthritis

By participating in an RA clinical trial at CRWF, individuals gain access to the latest therapies that may not yet be available outside of a research setting. These new treatments could potentially offer better relief from RA symptoms and improve overall health outcomes.

Contributing to Groundbreaking Research

Joining an RA clinical trial helps drive the development of new treatments and therapies that could benefit future generations of patients. Participants play a vital role in the advancement of RA research, contributing to discoveries that may lead to more effective treatments and better management options for the condition.

Receiving Specialized Clinical Care and Support

Participants in RA clinical trials at CRWF receive expert care from specialists in autoimmune diseases. They benefit from regular health evaluations, tailored treatment plans, and consistent monitoring to ensure their safety and well-being throughout the trial. This personalized attention often improves overall care and helps participants manage their condition more effectively.

The Role of Double-Blind Randomized Studies

In RA clinical trials, the use of a double-blind randomized study design helps eliminate bias. This means that participants are randomly assigned to receive either the experimental treatment or a placebo, and neither the participant nor the researcher knows which group they belong to. This approach ensures that the results of the trial are as objective and reliable as possible.

Ensuring Participant Safety and Tolerability

Safety is a top priority during RA clinical trials. Researchers closely monitor participants for side effects or adverse reactions to the study medication. Participants undergo regular health assessments, and the research team is always available to address any concerns or questions. This vigilant approach ensures that participants are well taken care of throughout their involvement in the study.

Maintaining Standard of Care in RA Research

While exploring new therapies, RA clinical trials at CRWF adhere to the standard of care for RA patients. This means that participants receive appropriate treatments to manage their condition, regardless of whether they are enrolled in a trial. This commitment to high standards of care ensures that participants receive the best possible treatment and support throughout the study.

Interested In Learning More

Enroll Now

Date of Birth(Required)
Privacy Policy(Required)
This field is for validation purposes and should be left unchanged.